📰 Bio Techne News
Page 5 - Bio Techne News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Techne. Real-time updates on events, politics, business and more.
November 7, 2023
StockNews.com lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a report published on Saturday. Several other brokerages also recently issued reports on TECH. Stephens reaffirmed an overweight rating and set a $100.00 price target on shares of Bio-Techne in a report on Wednesday, August 9th. TheStreet […]
November 5, 2023
Bio-Techne (NASDAQ:TECH – Free Report) had its target price cut by KeyCorp from $115.00 to $80.00 in a research note released on Wednesday, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. KeyCorp also issued estimates for Bio-Techne’s Q3 2024 earnings at $0.43 EPS and Q4 2024 earnings at $0.47 EPS. […]
November 3, 2023
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from $104.00 to $65.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 17.31% from the stock’s […]
November 3, 2023
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Equities researchers at Leerink Partnrs lowered their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.40 per share for the quarter, down from their prior estimate […]
November 3, 2023
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Investment analysts at KeyCorp increased their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. KeyCorp analyst P. Knight now expects that the biotechnology company will post earnings per share of $0.43 for the quarter, up from their previous estimate […]
October 31, 2023
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Bio-Techne from a b- rating to a c+ rating in a research report […]
October 31, 2023
GAAP Earnings Per Share Drops to $0.31 from $0.55 in the Previous Year
October 30, 2023
Rowland & Co. Investment Counsel ADV decreased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the quarter. Rowland & Co. […]
October 30, 2023
Bio-Techne Co. (NASDAQ:TECH – Get Free Report)’s share price was down 6.9% during trading on Monday . The stock traded as low as $55.38 and last traded at $55.42. Approximately 278,978 shares traded hands during trading, a decline of 71% from the average daily volume of 962,305 shares. The stock had previously closed at $59.54. […]
October 30, 2023
Rowland & Co. Investment Counsel ADV lowered its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the […]